Protective effect of plant extract from Onobrychis ebenoides on ovariectomy-induced bone loss in rats

被引:27
作者
Dontas, I [1 ]
Halabalaki, M
Moutsatsou, P
Mitakou, S
Papoutsi, Z
Khaldi, L
Galanos, A
Lyritis, GP
机构
[1] Univ Athens, Lab Res Musculoskeletal Syst, Sch Med, Athens, Greece
[2] Univ Athens, Sch Pharm, Dept Pharmacognosy & Chem Nat Prod, Athens, Greece
[3] Univ Athens, Sch Med, Biol Chem Lab, GR-11527 Athens, Greece
关键词
ovariectomy; rats; osteoporosis; phytoestrogen; bone mineral density; dual energy X-ray absorptiometry; histomorphometry;
D O I
10.1016/j.maturitas.2005.05.007
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 [法学]; 0303 [社会学]; 100203 [老年医学];
摘要
Objective: Certain plant extracts have been the object of recent studies due to their mild estrogenic action and their possible potential role in osteoporosis prevention and/or treatment. The present study was undertaken to investigate the possible protective effect of the aqueous solution of the plant Onobrychis ebenoides, with proven in vitro mild estrogenic action, on bone mass loss of the ovariectomized (Ovx) rat experimental model of osteoporosis. Methods: Forty intact female mature (10-month-old) Wistar rats were separated into three groups: Ovx, Ovx plus plant extract (Ph) and sham-operated (control). Ph administration in the drinking water at a dose of 300 mg/kg body weight/day commenced immediately after Ovx. Bone mineral density (BMD) values, percentage change from the baseline measurement and histomorphometry of the tibia, as well as body and uterine weight, were examined and compared between groups. Results: Comparison of BMD absolute values of the whole tibia of Ovx + Ph and Ovx animals at both 3 and 6 months post-Ovx were highly significant (p < 0.0005), showing a protective effect on treated animals. The extract did not appear to have such a beneficial effect on BMD of the proximal tibia of the treated animals compared to the Ovx animals after 3 months; however, a significant protective effect was observed at 6 months post-Ovx in treated animals compared to the Ovx (p = 0.015). When the % changes from baseline measurement of the whole tibia of Ovx + Ph and controls were compared, there was no significant difference at 3 or 6 months, demonstrating a highly protective effect; the respective comparisons of proximal tibia % changes did not display such protection. Body and uterine weight comparisons showed no significant difference between Ovx and treated rats, whereas, the level of significance for each group compared to controls was p < 0.0005. Conclusions: The Ph studied showed a highly significant protective effect on BMD of the whole tibia of Ovx rats after 3 and 6 months of treatment, compared to the non-treated animals. Its effect on the proximal tibia was less pronounced, but also statistically significant compared to non-treated rats after 6 months. The lack of significant effect on body and uterine weight is in favor of its selective estrogen receptor modulator-like activity, and merits further studies. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:234 / 242
页数:9
相关论文
共 29 条
[1]
Soy isoflavones: No effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year [J].
Anderson, JJB ;
Chen, XW ;
Boass, A ;
Symons, M ;
Kohlmeier, M ;
Renner, JB ;
Garner, SC .
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2002, 21 (05) :388-393
[2]
Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content [J].
Arjmandi, BH ;
Birnbaum, R ;
Goyal, NV ;
Getlinger, MJ ;
Juma, S ;
Alekel, L ;
Hasler, CM ;
Drum, ML ;
Hollis, BW ;
Kukreja, SC .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1998, 68 (06) :1364S-1368S
[3]
Bryant HU, 1998, P SOC EXP BIOL MED, V217, P45
[4]
Cassidy Aedin, 2003, J Br Menopause Soc, V9, P17, DOI 10.1258/136218003100322099
[5]
Prevention of osteopaenia by phyto-oestrogens: animal studies [J].
Coxam, V .
BRITISH JOURNAL OF NUTRITION, 2003, 89 :S75-S85
[6]
COXAM V, 2001, ANN NUTR METAB, V45, P221
[7]
Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women [J].
Delmas, PD ;
Bjarnason, NH ;
Mitlak, BH ;
Ravoux, AC ;
Shah, AS ;
Huster, WJ ;
Draper, M ;
Christiansen, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (23) :1641-1647
[8]
*FDA, 1994, GUID PRECL CLIN EV A
[9]
Soy isoflavones: hope or hype? [J].
Fitzpatrick, LA .
MATURITAS, 2003, 44 :S21-S29
[10]
Three new arylobenzofurans from onobrychis ebenoides and evaluation of their binding affinity for the estrogen receptor [J].
Halabalaki, M ;
Aligiannis, N ;
Papoutsi, Z ;
Mitakou, S ;
Moutsatsou, P ;
Sekeris, C ;
Skaltsounis, AL .
JOURNAL OF NATURAL PRODUCTS, 2000, 63 (12) :1672-1674